The Institute
Our Values
Collaboration
Research Infrastructure
Work With Us
Translational Research
Research
Advanced Materials and Drug Delivery
Cell and Tissue Engineering
Nanotechnology
Neural Engineering
Single Cell Technologies
BioInnovations in Brain Cancer
Team
Equipment
Core Equipment
Core Equipment Safety Training
Shared Equipment
News & Events
Research Publications
The Shea group investigates antigen-conjugated nanoparticle treatment
« Previous
Next »
Posted on 05 Jul
The Shea group investigates antigen-conjugated nanoparticle treatment
« Back to News
The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.
Work With Us
